Cantharidin
CAS 56-25-7 1 FDA-DMF supplierSmall Molecule
Overview
Cantharidin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL48449).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Cantharidin expires 19 Feb 2041 and exclusivity 20 Jul 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (1S,2R,6S,7R)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione
- Canonical SMILES
- C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3
- InChIKey
- DHZBEENLJMYSHQ-XCVPVQRUSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.